22q11.2DS is characterized by neuropsychiatric abnormalities, such as schizophrenia [357], attention-deficit hyperactive disorder, anxiety, depression, and ASD [358]
McCLUNG M, Mobley D, Geller J, Sullivan M, Grayhack J, Wessells H, Kadmon D, Flanagan M, Zhang GK, Schmidt J, Taylor AM, Lee M, Waldstreicher J
10.1515/revneuro-2011-0059 367
Many notice a lift within a few days
A subsequent Japanese survey ( N = 500) also assessed the willingness of patients with T2D to initiate different GLP-1RA therapies based on unbranded therapy profiles
Naming the emotions and dealing with those feelings with honesty matters because rumination often keeps us stuck, and humans are remarkably poor at predicting how we will feel after a major change whether that change is taking a GLP-1 or not